Applied Clinical Trials
With the onset of the COVID-19 pandemic, clinical trial sponsor companies and CROs hastened to implement virtual trial technologies. The virtual visits and digital data exchange would enable them to start or continue studies, despite government mandates requiring patients and staff to stay at home.
During the COVID-19 lockdown, in April and May 2020, ERT surveyed clinical professionals on how the demands of the pandemic were affecting their organizations’ use and planned use of virtual trial technologies. Download the free eBook, Virtual Trials and the COVID-19 Pandemic: The State of Clinical Trials, to learn about their responses and industry trends.
Key takeaways from the report include: